𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Determinants of disability in alzheimer's disease

✍ Scribed by Orazio Zanetti; Angelo Bianchetti; Giovanni B. Frisoni; Renzo Rozzini; Marco Trabucchi


Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
488 KB
Volume
8
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The aim of the study is to evaluate risk factors of disability in a population of 64 patients affected by Alzheimer's disease. The subjects were consecutively recruited at the day hospital service of an Alzheimer's dementia care unit. The associations between activities of daily living and age, cognitive status, affective status, cognitive symptoms duration and number of diseases were evaluated within a multidimensional assessment programme. Cognitive performance, as detected by the Mini‐Mental Status Examination, was the main independent predictor of disability; other independent predictors of disability were age and cognitive disease duration. Number of diseasesβ€”physical and mental–and self‐rated depression scores were not independently associated with disability. It is concluded that, in a population of Alzheimer's patients, cognitive impairment has a high impact on the aetiology of disability, but other variables such as age and disease duration should be taken into account. It is also suggested that cognitive performance is the most important indicator of performance in activities of daily living.


πŸ“œ SIMILAR VOLUMES


Determinants of costs of care for patien
✍ Linus JΓΆnsson; Maria Eriksdotter JΓΆnhagen; Lena Kilander; Hilkka Soininen; Merja πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 112 KB πŸ‘ 2 views

## Background: Alzheimer's disease (ad), the most common cause of dementia, is a major cause of disability and care burden in the elderly. this study aims to estimate the costs of formal and informal care and identity determinants of care costs. ## Materials and methods: Two hundred and seventy-t

Understanding disability in Parkinson's
✍ Lisa M. Shulman πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

## Abstract Even with optimal therapy, it is inevitable that the symptoms of Parkinson's disease (PD) progress and gradually result in disability in the performance of daily activities. Delay and prevention of disability is among the highest priorities in the clinical management of PD. Understandin

ALZHEIMER'S DISEASE IN POLAND
✍ B. SZCZEPANOWSKA πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views
Neuroplasticity in Alzheimer's disease
✍ Bruce Teter; J. Wesson Ashford πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 277 KB

## Abstract Ramon y Cajal proclaimed in 1928 that β€œonce development was ended, the founts of growth and regeneration of the axons and dendrites dried up irrevocably. In the adult centers the nerve paths are something fixed, ended and immutable. Everything must die, nothing may be regenerated. It is

Tetrahydroaminoacridine in Alzheimer's d
✍ B. Davies; D. Andrewes; R. Stargatt; D. Ames; V. Tuckwell; S. Davis πŸ“‚ Article πŸ“… 1990 πŸ› John Wiley and Sons 🌐 English βš– 445 KB πŸ‘ 1 views

Tetrahydroaminoacridine (THA), a centrally acting anticholinesterase, was used in a two-month, double-blind, placebo-controlled crossover trial to treat 10 patients meeting DSM-111-R criteria for dementia of the Alzheimer type. Eight patients continued to take THA for a further three months. Nausea